Vertex Pharmaceuticals (VRTX) | Stock Discussion Forums

Sponsor

Biotech / Medical: Vertex Pharmaceuticals (VRTX)

Posts: 1169 | Member SubjectMarks: 77 | No Bans

SI Sentiment for VRTX: Insufficient votes accumulated

Add SubjectMark | Hide Original Post | Show Chart | Poster Summary | Share This Board

Moderated By: David Lieberman -- (Not Moderated) -- Started: 8/15/1996 3:03:00 PM Revision History

Does anybody follow this company?

I bought it about 15 months ago on the recommendation of a
Biochemist friend who said they had their scientific act
together.

Does anybody have a feeling for their business acumen?

They seem to be adept at generating publicity but they do
not seem to have real products yet.

Previous 10 | Next 10 | View Recent | Post Message

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Date
1169	Quite impressive results, vx-661.... $79/share. Hope you have a full boat load	scaram(o)uche	-	04/18/2013 04:29 PM
1168	VX-787 Showed Significant Antiviral Activity and Reduced the Severity and Durati	tnsaf	-	03/07/2013 01:00 AM
1167	Vertex Presents New Phase 3 Data that Showed People with Hepatitis C Treated wit	tnsaf	-	11/10/2012 12:01 PM
1166	Data from Viral Kinetic Study Showed Rapid Reduction of HCV RNA with ALS-2200 (V	tnsaf	-	11/10/2012 11:34 AM
1165	Vertex Announces New Data on ALS-2200 in People With Hepatitis C, Supporting Adv	tnsaf	-	09/25/2012 01:59 PM
1164	Vertex Announces Appointment of Stuart A. Arbuckle as Chief Commercial Officer	tnsaf	-	09/04/2012 10:16 AM
1163	this looks pretty wild... pnas.org	mopgcw	-	07/25/2012 08:08 PM
1162	You are invited to participate in: Vertex Pharmaceuticals Incorporated Second Q	tnsaf	-	07/18/2012 11:27 PM
1161	Vertex shares fall as investors doubt drug data By Toni Clarke and Bill Berkr	tnsaf	-	06/29/2012 01:29 AM
1160	Data From Follow-Up Study of KALYDECO(TM) (ivacaftor) Showed Durable Improvement	tnsaf	-	06/08/2012 12:34 AM
1159	VRTX will not make an HCV acquisition, according to CEO, Jeff Leiden on today’s	DewDiligence_on_SI	1	06/06/2012 05:01 PM

Go to reply# or date (mm/dd/yy):